Institut National De La Sante Et De La Recherche Medicale

Université De Nantes

Yannick Guilloux

Francine Jotereau

Thierry R Boon-Falleur

Sophie Lucas

Vincent Brichard

Emmanuelle Godefroy

Elisabeth Diez

Agnès Aubry

Peptides derived from MMP-2 metalloproteinase that form T cell epitopes when presented by MHC Class I molecules. Anti-tumor therapy using these peptides.

Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy

New tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as NAG tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as NAG coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are described.

Methods for determining expression of NAG tumor rejection antigen

Isolated nucleic acid molecules, peptides which form complexes with MHC

Growing community of inventors

Nantes, France

Yannick Guilloux